Supplementary Appendix to Safety and efficacy of a pentavalent human– bovine (WC3) reassortant rotavirus vaccine.

Timo Vesikari; David O. Matson; Penelope Dennehy; Pierre Van Damme; Mathuram Santosham; Zoe Rodriguez; Michael J. Dallas; Joseph F. Heyse; Michelle G. Goveia; Steven B. Black; Henry R. Shinefield; Celia D. C. Christie; Samuli Ylitalo; Robbin F. Itzler; Michele L. Coia; Matthew T. Onorato; Ben A. Adeyi; Gary S. Marshall; Leif Gothefors; Dirk Campens; Aino Karvonen; James P. Watt; Katherine L. O'Brien; Mark J. DiNubile; H. Fred Clark; John W. Boslego; Paul A. Offit; Penny M. Heaton

Journal Article

Supplementary Appendix to Safety and efficacy of a pentavalent human– bovine (WC3) reassortant rotavirus vaccine.

Vesikari T
Matson D
Dennehy P
et al.

The New England journal of medicine (2006) 354 23-33

N/ACitations

1Readers

Cite

CITATION STYLE

APA

Vesikari, T., Matson, D. O., Dennehy, P., Van Damme, P., Santosham, M., Rodriguez, Z., … Heaton, P. M. (2006). Supplementary Appendix to Safety and efficacy of a pentavalent human– bovine (WC3) reassortant rotavirus vaccine. The New England Journal of Medicine, 354, 23–33.

Supplementary Appendix to Safety and efficacy of a pentavalent human– bovine (WC3) reassortant rotavirus vaccine.

Cite

Register to see more suggestions